KCNH1 variants associated with neurodevelopmental disorders exhibit prominent gain of function

Clicks: 11
ID: 337431
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #448 of 456 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 456 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Pathogenic variants in KCNH1, encoding the human ether-á-go-go voltage-gated potassium channel (EAG1, KV10.1), are associated with the neurodevelopmental disorders Temple-Baraitser syndrome (TBS), Zimmermann-Laband syndrome (ZLS), epileptic encephalopathy, and other undefined neurodevelopmental disorders. Investigating the functional consequences of KCNH1 variants can provide information about molecular and cellular pathophysiological mechanisms and help guide therapeutic directions. In this study, we determined the functional properties of 26 disease-associated KCNH1 variants including three recurrent and six that were previously unpublished. Findings were compared to the wildtype (WT) channel along with six rare population variants. Our approach used automated patch clamp recording of heterologously expressed KCNH1 variants in both the homozygous state (variant alone) and the clinically-relevant heterozygous state (variant co-expressed with WT channels). We also examined the impact of alternative splice isoforms on functional consequences of specific variants. We demonstrated that the majority of disease-associated KCNH1 variants exhibit features consistent with gain-of-function including hyperpolarized voltage-dependence of activation, accelerated activation kinetics, or both that promote hyperpolarization of the resting membrane potential. By contrast, one unique variant discovered previously in an autism cohort had a depolarized voltage-dependence of activation and was associated with a depolarized resting potential in cells. Pharmacological testing of KCNH1 variants demonstrated differences in potency for channel block by imipramine and an investigational non-selective potassium channel blocker (LY97241) for specific variants. Collectively, our findings support gain-of-function as the most common, albeit not exclusive, molecular mechanism underlying KCNH1-related disorders and suggest opportunities for potential therapeutic drug repurposing strategies for these conditions.
Reference Key
openalex_W7224015398 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Christopher H. Thompson, Christine Q. Simmons, Isabella K. He, Nirvani P. Jairam, Reshma R. Desai, Esther Cha, Alexandra E. Hong, Jean‐Marc DeKeyser, Linda Laux, Michaelle Jinnette, Carlos G. Vanoye, Alfred L. George
Are you one of these authors? Claim your profile
Journal Brain research
Year 2026
DOI
10.1093/brain/awag373
URL
https://doi.org/10.1093/brain/awag373
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.